Literature DB >> 26745431

The Fallacy of Assigning Chamber Specificity to iPSC Cardiac Myocytes from Action Potential Morphology.

Christopher Kane1, David T M Du1, Nicola Hellen1, Cesare M Terracciano2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26745431      PMCID： PMC4805873          DOI： 10.1016/j.bpj.2015.08.052

Source DB:  PubMed          Journal:  Biophys J        ISSN： 0006-3495            Impact factor:   4.033


× No keyword cloud information.
  8 in total

Review 1.  The polyclonal origin of myocyte lineages.

Authors:  T Mikawa; D A Fischman
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

2.  Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density.

Authors:  David T M Du; Nicola Hellen; Christopher Kane; Cesare M N Terracciano
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

3.  Automated grouping of action potentials of human embryonic stem cell-derived cardiomyocytes.

Authors:  Giann Gorospe; Renjun Zhu; Michal A Millrod; Elias T Zambidis; Leslie Tung; Rene Vidal
Journal:  IEEE Trans Biomed Eng       Date:  2014-09       Impact factor: 4.538

4.  Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells.

Authors:  Glenna C L Bett; Aaron D Kaplan; Agnieszka Lis; Thomas R Cimato; Emmanuel S Tzanakakis; Qinlian Zhou; Michael J Morales; Randall L Rasmusson
Journal:  Heart Rhythm       Date:  2013-09-19       Impact factor: 6.343

5.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

Authors:  Alessandra Moretti; Milena Bellin; Andrea Welling; Christian Billy Jung; Jason T Lam; Lorenz Bott-Flügel; Tatjana Dorn; Alexander Goedel; Christian Höhnke; Franz Hofmann; Melchior Seyfarth; Daniel Sinnecker; Albert Schömig; Karl-Ludwig Laugwitz
Journal:  N Engl J Med       Date:  2010-07-21       Impact factor: 91.245

6.  Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Authors:  Ping Liang; Feng Lan; Andrew S Lee; Tingyu Gong; Veronica Sanchez-Freire; Yongming Wang; Sebastian Diecke; Karim Sallam; Joshua W Knowles; Paul J Wang; Patricia K Nguyen; Donald M Bers; Robert C Robbins; Joseph C Wu
Journal:  Circulation       Date:  2013-03-21       Impact factor: 29.690

7.  Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.

Authors:  Harsha D Devalla; Verena Schwach; John W Ford; James T Milnes; Said El-Haou; Claire Jackson; Konstantinos Gkatzis; David A Elliott; Susana M Chuva de Sousa Lopes; Christine L Mummery; Arie O Verkerk; Robert Passier
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

8.  The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.

Authors:  Christopher Rao; Themistoklis Prodromakis; Ljudmila Kolker; Umar A R Chaudhry; Tatiana Trantidou; Arun Sridhar; Claire Weekes; Patrizia Camelliti; Sian E Harding; Ara Darzi; Magdi H Yacoub; Thanos Athanasiou; Cesare M Terracciano
Journal:  Biomaterials       Date:  2012-12-20       Impact factor: 12.479
  8 in total
  8 in total

1.  Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes.

Authors:  Glenna C L Bett; Aaron D Kaplan; Randall L Rasmusson
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

2.  Correlation between human ether-a-go-go-related gene channel inhibition and action potential prolongation.

Authors:  P Saxena; M P Hortigon-Vinagre; S Beyl; I Baburin; S Andranovits; S M Iqbal; A Costa; A P IJzerman; P Kügler; E Timin; G L Smith; S Hering
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 9.473

Review 3.  Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.

Authors:  Simona Casini; Arie O Verkerk; Carol Ann Remme
Journal:  Cardiovasc Drugs Ther       Date:  2017-06       Impact factor: 3.727

4.  Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients.

Authors:  Tadashi Takaki; Azusa Inagaki; Kazuhisa Chonabayashi; Keiji Inoue; Kenji Miki; Seiko Ohno; Takeru Makiyama; Minoru Horie; Yoshinori Yoshida
Journal:  Stem Cells Int       Date:  2019-03-06       Impact factor: 5.443

5.  Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes.

Authors:  Sherri M Biendarra-Tiegs; Xing Li; Dan Ye; Emma B Brandt; Michael J Ackerman; Timothy J Nelson
Journal:  Stem Cells Dev       Date:  2019-04-17       Impact factor: 3.272

6.  Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Ibrahim El-Battrawy; Siegfried Lang; Zhihan Zhao; Ibrahim Akin; Gökhan Yücel; Sophie Meister; Bence Patocskai; Michael Behnes; Boris Rudic; Erol Tülümen; Volker Liebe; Malte Tiburcy; Jennifer Dworacek; Wolfram-Hubertus Zimmermann; Jochen Utikal; Thomas Wieland; Martin Borggrefe; Xiao-Bo Zhou
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

7.  Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.

Authors:  Weizhen Li; Julie L Han; Emilia Entcheva
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-28       Impact factor: 4.733

8.  Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.

Authors:  Christina Schmid; Najah Abi-Gerges; Michael Georg Leitner; Dietmar Zellner; Georg Rast
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.